Page 2 - Data Published News Today

Banks Complete Stablecoin Pilot, Crypto Indices and Web3 Solutions Launch - According to recent reports, a major German bank and an affiliate of a major British bank...

FOR IMMEDIATE RELEASE 2023 Second-Quarter reported sales growth of 6.3% to $25.5 Billion with operational growth of 7.5%* and adjusted operational...

2023 Second-Quarter reported sales growth of 6.3% to $25.5 Billion with operational growth of 7.5%* and adjusted operational growth of 6.2%*. Operational growth excluding COVID-19 Vaccine of...

Eli Lilly and Company announced that The New England Journal of Medicine published detailed results from the BRUIN Phase 1/2 trial evaluating the efficacy and safety of an investigational use of...

Issuer: Immunic, Inc. / Key word(s): Scientific publication Immunic Announces That Vidofludimus Calcium Acts as Potent Nurr1 Activator, Reinforcing Neuroprotective Potential in Multiple Sclerosis

According to a recent report, Ethereum’s ether (ETH) staking rewards “hit a record 8.6% post-Merge, with validators earning $46 million in the first…

Latest news on Novavax and NVAX stock, with coverage of the American biotechnology company that develops vaccines to counter serious infectious diseases.

Progress continued on the IMPAHCT global Phase 2b/Phase 3 clinical trial of AV-101 for pulmonary arterial hypertension (PAH) Expanded intellectual...

Phase 1 Clinical Trial for Orally Disintegrating Tablet Formulation of Sebetralstat Completed - Sebetralstat Data Published in the Journal of Medicinal Chemistry and Xenobiotica - Sebetralstat Phase

- Strong preclinical Data, recently Published in the International Journal of Molecular Sciences, from eight U.S government-funded in-vivo Opaganib studies, ...